Introduction
Technological advances in biological experimentation are now enabling researchers to investigate living systems on an unprecedented scale by studying genomes, proteomes or molecular networks in their entirety. Genomics technologies have led to a paradigm shift in biological experimentation because they measure ("profile") most or even all components of one class (e.g. transcripts, proteins etc.) in a highly parallel way. Whether gene expression analysis using microarrays, proteome and metabolome analysis using mass-spectrometry or large-scale screens for genetic interactions, high-throughput profiling technologies provide a rich source of quantitative biological information that allows researchers to move beyond a reductionist approach by both integrating and understanding interactions between multiple components in cells and organisms ( Figure 1 ; for a recent update of bioinformatics tools see Plitzschke and Hirt, 2009 ). Currently, most genomics experiments involve profiling transcripts, proteins or metabolites. Increasing efforts to complement molecular data with phenotypic information will further advance our understanding of the quantitative relationships between molecules in directing systems behavior and function. In the following update we will briefly review recent advances in the field and highlight advantages and limitations of current approaches to develop models of genetic and molecular networks that aim to describe emergent properties of plant systems.
Genomics technologies: the power of genome-scale quantitative data resolution

Profiling transcriptomes
Transcript profiling offers the largest coverage and a wide dynamic range of gene expression information and can often be performed genome-wide. Microarrays are currently most popular for transcript profiling and can be readily afforded by many laboratories. Various commercial and academic microarray platforms exist that vary in genome coverage, availability, specificity and sensitivity (Tab. 1). Microarrays manufactured by Affymetrix are probably most commonly used in plant biology (Redman et al., 2004 , Rehrauer et al., 2010 , but commercial arrays from Agilent or arrays from the academic CATMA consortium are often used as well (for review see Busch and Lohmann, 2007) . Serial analysis of gene expression (SAGE) and massively parallel signature sequencing (MPSS) are well-established alternatives to microarrays. Both techniques can be superior to microarrays because they do not depend on prior probe selection. More recently, direct sequencing of transcripts by high-throughput sequencing technologies (RNA-Seq) has become an additional alternative to microarrays and is superseding SAGE and MPSS (Busch and Lohmann, 2007) . Like SAGE and MPPS, RNA-Seq does not depend on genome annotation for prior probe selection and avoids biases introduced during hybridization of microarrays. On the other hand, RNA-Seq poses novel algorithmic and logistic challenges, and current wet-lab RNA-Seq strategies require lengthy library preparation procedures. Therefore, RNA-Seq is the method of choice in projects using non-model organisms and for transcript discovery and genome annotation. Because of their robust sample processing and analysis pipelines, often microarrays are still a preferable choice for projects that involve large numbers of samples for profiling transcripts in model organisms with wellannotated genomes. Tools such as Genevestigator (Hruz et al., 2008) and MapMan (Usadel et al., 2009 ) allow researchers to organize large gene expression data sets and analyze them for relational networks within a single experiment or across many experiments (contextual metaanalysis).
Profiling epigenomes and transcription factor binding
Much control of gene expression occurs at the level of transcription, and information on genome-wide chromatin profiles ("epigenomes") and transcription factor binding to promoters is needed to decipher the inherent logic of transcriptional regulation. Chromatin immunoprecipitation (ChIP) coupled to microarray analysis (ChIP-chip) or high-throughput sequencing (ChIP-Seq) can generate such data. In plants, DNA-methylation, repressive and activating chromatin marks as well as histone variants have been mapped onto the genome (for review see Zhang 2008) , but because such marks are expected to differ between cell types and developmental stages, more targeted epigenome profiling is needed in the future. Targeted analysis of DNA-methylation during seed development, for instance, revealed unexpected genome-wide demethylation (Hsieh et al., 2009; Gehring et al., 2009 ). ChIP-chip was also used for global mapping of binding sites of transcription factors such as TGA2 and SEP3 and to refine definitions of binding motifs that were previously determined by in vitro experiments (ThibaudNissen et al. 2006; Kaufmann et al., 2009) . It was found that SEP3 is a key component in the regulatory transcriptional network underlying the formation of floral organs. In a comparative experiment ChIP-chip and ChIP-Seq gave very similar results (Kaufmann et al., 2009) . This is encouraging because bias introduced by the profiling technology seems not to severely confound studies on global protein binding profiles. Currently, work is going on in several laboratories to establish a compendium of transcription factor binding sites in Arabidopsis. Thus, more genome-wide data sets are in reach that could provide causal explanations for transcriptional profiles.
Profiling proteomes
Gene expression is a highly regulated, multi-step process, and it is impossible to predict the exact protein concentration or activity from the measurement of mRNA levels. Proteomics has therefore become a key tool in systems biology because it provides quantitative and structural information about proteins, which are the major functional determinants of cells. Phenotypic alterations associated with genetic perturbations often result from changes in protein accumulation or stability, or changes in protein posttranslational modifications, which can disrupt protein-protein interactions and network connectivity (Gstaiger and Aebersold, 2009 ).
Quantitative protein information complements data from transcriptional profiling and metabolomics. It represents a key link between different levels of gene expression regulation and provides insights into their causal relationships. Unlike transcriptional profiling, however, comprehensive proteome analysis remains challenging, and information about proteome complexity and dynamics is far from complete (Cox and Mann, 2007) . Moreover, the rate of metabolite synthesis is often controlled by regulatory posttranslational modifications of enzymes and not only by their abundance. Information about quantitative relationships between RNA and protein accumulation, posttranslational protein modifications and metabolite levels is therefore required to fully understand regulatory circuits that control systems behavior and function.
Protein quantification can be absolute or relative (Table 1) . While relative protein quantification mostly depends on stable isotopes, absolute quantification of comprehensive protein sets is much more difficult. Recent improvements in statistical data evaluation and increasing accuracy of mass spectrometry instruments allow quantifying large numbers of proteins in shotgun-type experiments on the basis of spectral counting (Lu et al., 2007) . This method is reliable and comparable to most other quantification methods, including 2D-PAGE based protein staining, however, the protein dataset must be very large. More accurate information about the exact in vivo concentration of individual proteins requires specialized targeted approaches.
Current methods for absolute protein quantification include isotope dilution strategies using isotopically labeled peptides as internal standards (for a comprehensive review see Brun et al., 2009 ). Signature peptides for internal standardization are characteristic for a protein of interest, and are often referred to as proteotypic peptides (PTP). In AQUA (Absolute Quantification), PTPs are added to analytical protein samples in known concentrations. The protein samples are subsequently scanned for PTPs of interest. Using the extracted ion chromatograms (XIC) the "native" peptide can then be quantified relative to the added PTP (Kuster et al., 2005) . A modification of this strategy accounts for quantification errors derived from incomplete tryptic digest of the analytical sample. In QconCAT (quantification concatamer), a synthetic protein with concatenated, isotopically labeled PTPs is expressed as recombinant protein in a biological system, added to the sample prior to Trypsin treatment and carried through the digestion procedure, such that losses from incomplete tryptic digestion will also affect the quantity of the PTPs. Both, the AQUA and the QconCAT strategies are incompatible with upstream fractionation techniques, which is a potential problem in biomarker quantification. A way around this constraint is offered by the PSAQ strategy, which uses isotopically labeled protein standards that are added to the sample prior to fractionation. Several prediction tools exist that help to define the most suitable PTPs for the detection and quantification of specific proteins.
However, only experimental data provide the necessary reliability for PTP selection because in practice PTP prediction often deviates from experimental observations. Therefore, efforts are underway to catalogue PTPs for model organism proteomes. Proteome maps for Arabidopsis generated PTPs for 4105 proteins, many of which may be optimal for the detection of proteins in different organs (Baerenfaller et al., 2008) .
Similar quantitative approaches are also used for metabolites, because in addition to RNA and protein levels, understanding the function and behavior of metabolic networks requires global information about metabolite concentrations and fluxes as well. In recent years, much progress has been made in metabolic profiling, and the interested reader is referred to recent reviews (e.g. Issaq et al., 2009 and references therein).
Transcripts and more transcripts: what can we learn from gene expression analysis?
During the analysis of large gene expression data sets the researcher is often confronted with several questions. How do we interpret a mathematical relationship between genes or between genes and conditions? For example, does a high correlation between two genes mean that they are co-regulated, or could one of them be the positive regulator of the other? Or can we assume that they are involved in the same pathway or biological process? Although it is not possible to answer these questions conclusively from gene expression data alone, a number of parallel approaches can be useful to distinguish between different scenarios. For example, Gene Ontology enrichment analysis can provide confidence that a given gene cluster is enriched in genes that are known to have a common function, cellular location, or biological process.
Similarly, conserved cis-regulatory elements in the promoters of genes from the same cluster indicate that they are likely co-regulated. Although these methods do not establish proof of the nature of the relationship between genes, they allow formulating hypotheses that can be tested in the laboratory. In summary, although gene expression analysis by itself is rather descriptive (i.e. describing how genes respond to various test conditions or tissues), it is a valuable validation tool and an excellent starting point to study novel cellular process and to formulate novel hypotheses.
A major challenge of genome-scale transcription analysis is the very large number of predictors (genes) compared to a generally small number of measurements (microarrays). Without appropriate statistical measures to correct for multiple testing and including false discovery rates, almost any approach will yield significant genes, including many false positives. The creation of large databases in recent years has brought an additional layer of complexity and precautions to take. For example, large databases such as Genevestigator (Hruz et al., 2008) not only profile a large number of genes, but also allow contextual meta-analysis of several hundred conditions, each of which is covered by only a small number of replicates (usually 3-5).
While some genes will respond to a small number of conditions and therefore their expression is easier to contextualize and interpret, other genes will respond to dozens or hundreds of conditions. It is often very difficult to distinguish primary effects from secondary effects, because the intensity of the effect does not necessarily relate to the direct involvement of the corresponding condition in regulating a specific target gene. Breaking down these effects into local patterns (e.g. by using a biclustering algorithm; Prelic et al., 2006) This technique was successfully applied to measure genome-wide expression profiles in more than 15 root regions establishing a compendium of "digital in situ" data (Birnbaum et al., 2003; Cartwright et al., 2009 ). It will be interesting to test, whether this approach can also be used for protein profiling. Polysome immunopurification is based on the tissue-specific expression of the FLAG-tagged ribosomal protein L18 in transgenic plants (Zanetti et al., 2005) . In contrast to micropipetting, LCM and sorting of protoplasts, which all can be used to isolate total cellular RNA, polysome immunopurification can be used to isolate transcripts that are associated with ribosomes ("translatome"). Discrepancies between total RNA levels and representation translatome can reveal regulation at the level of translation (Mustroph et al., 2009 ). In the future, translatome data sets, which bridge transcriptomics and proteomics, can help to interpret unusual transcript:protein ratios (see below).
Alternatively, it is possible to identify cell-type specific transcripts and proteins by comparing wild-type plants with mutants that lack specific cells or tissue types. In Arabidopsis, for instance, a series of homeotic mutants that lack various floral organs was used to identify several hundreds of floral organ specific genes (Wellmer et al., 2004) . If no appropriate mutants exist, specific cell types can be genetically ablated by expression of a cell-autonomous toxin, such as diphtheria toxin subunit A (DT-A) or RNase, under the control of cell type-specific promoters.
Again, these approaches have been proven to work for transcript profiling (Tung et al. 2005) but it remains to be tested whether they could be useful for protein profiling.
Decreasing complexity by organizing organ and subcellular proteomes
Systematic analysis of accurate protein localization is essential to understand cellular networks in the context of compartmentalization, which is a fundamental design principle of eukaryotic cells. Organelle proteomics has therefore become a very active research field. Until recently, the protein inventory of cell organelles was based on proteins from isolated organelles, such as mitochondria, chloroplast and peroxisomes (Lilley and Dupree, 2007; Baginsky, 2009 ). This approach has limitations because true low-abundant organelle proteins often cannot be distinguished from contaminating proteins. Two approaches have been used to deal with this problem. First, a recently reported isolation procedure for mitochondria used the electrostatic characteristics of the mitochondrial surface to separate mitochondria from other organelles in an electric field. This procedure results in mitochondria preparations with higher purity, but the yield is low (Eubel et al., 2007) . Second, information about the quantitative distribution of proteins along density gradients has been used to determine if a protein was enriched by the organellar isolation procedure. In practice, the abundance distribution profile of unknown proteins is compared to known organelle marker proteins. This strategy is referred to as "protein correlation profiling" (Foster et al., 2006) or LOPIT (Dunkley et al., 2006) . Both procedures, however, are of limited use for the analysis of proteome dynamics in response to a stimulus because the long time that is needed to isolate and purify organelles affects their proteome properties. This is especially critical for transient posttranslational protein modifications. Thus, proteome dynamics is best analyzed at the cell or tissue level, followed by sorting of proteins into their respective organelle a posteriori. This strategy is now possible because substantial information about the protein complement of different cell organelles has accumulated (a comprehensive collection of proteome databases is for example available in Lu and Last, 2009) . The SUBA database is most suitable for this purpose, because it is frequently updated and well maintained. SUBA generates lists of organelle proteins using reliability criteria, for example evidence from several different proteomics studies, targeting prediction, or GFPlocalization assays, or a combination of this information (Heazlewood et al., 2007) . For the chloroplast, two proteome reference tables have been established (Yu et al., 2008; Reiland et al., 2009) . The overlap between these two proteome reference tables has generated a list of 1156 proteins that can be considered high-confidence chloroplast proteins. (Baerenfaller et al., 2008) . The lowest correlation was observed for seeds, which accumulate stable storage proteins whose abundance is largely uncoupled from transcription. The highest correlation was obtained in leaves, suggesting that the most abundant photosynthetic proteins are predominantly regulated at the transcriptional level. It is clear that such a genome-scale analysis only offers a global view of regulatory events and does not allow a systematic assessment of individual enzyme regulation. A more refined comparison of protein and transcript levels showed that the correlation between transcript and protein abundance can vary significantly between different pathways (Kleffmann et al., 2004 ) and most likely also between different enzymes in the same pathway. Figure 2 shows an example of a correlation analysis of a representative leaf transcriptome and proteome for a selection of 345 genes/proteins from primary and secondary metabolism pathways. Although the data was collected from various sources and summarized (see also Baerenfaller et al., 2008) , the proteinto-transcript ratio was similar for most proteins, indicating that this analysis is robust. The majority of proteins in most metabolic pathways were found within the typical protein-totranscript range. Only a small fraction of proteins deviated significantly from these ratios, both up or down and to a similar extent. This preliminary genome-scale correlation analysis revealed combined and consistent effects for particular pathways that are worth considering in further experimentation, for example by taking into account the effects of circadian rhythm, light, and nutrient status. The generation of protein and transcript data from the exact same samples is urgently needed to precisely address these questions and to understand how and under which conditions the protein-to-transcript ratio varies.
From genes and proteins to network discovery
Network discovery is a generic term describing the effort of elucidating the nature of relationships between molecules and associated properties emerging from of a biological network. Multiple types of networks have been described with respect to the types of molecules involved and the dimension of the molecular network (genome-scale or small scale). While genome/proteome/metabolome-scale analyses aim at identifying novel properties of the global network, smaller scale networks usually incorporate additional data types that cannot be obtained on a global scale and use models that allow a more precise prediction of network behavior. A more recent development is the integration of various networks into an evolutionary ecology of networks, in which networks are considered as strategies that interact and possibly compete for resources (Weitz et al., 2007) .
Metabolic network reconstructions have received increasing attention in the last few years and several genome-scale models are now available for microorganisms and human tissues.
However, none of the existing models can currently provide a full view of all reactions in a cell organelle. For example, even the most advanced genome-scale models for Saccharomyces cerevisiae only contain ~1,200 of the predicted ~2,200 metabolic genes and only ~70% of the modeled reactions are functional (Feist et al., 2009 ). The situation is worse for higher organisms, and for plants no genome-scale model exists to date although efforts to build knowledge databases are underway (Tzemetzis et al., 2008) . Progress in metabolic network reconstruction critically depends on the functional annotation of the genes that encode proteins with unknown functions, which is still the case for about 30% of the Arabidopsis genome. Accordingly, current plant metabolic network reconstruction focuses mostly on specific pathways such as fatty acid synthesis or aspartate metabolism (Chen et al., 2009; Curien et al., 2009 ). Systematic efforts to improve genome annotation are underway, and the community is well connected via TAIR (www.arabidopsis.org), which supports and facilitates the exchange of material and information. One example of such a functional characterization pipeline is the "Chloroplast 2010" project that was launched at the Michigan State University (Lu et al., 2008) .
Here, homozygous knockout lines for all known chloroplast proteins are generated and phenotypically characterized, also at the metabolite level. In brief, a dramatic improvement in the functional annotation of genes is key to networks with improved quality and consistency.
Similar efforts are underway to construct plant transcriptional regulatory networks, for example (Turck et al., 2007) and a detailed description of the different quantification techniques along with examples for application in the plant field is available (Baginsky, 2009 
